Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
Men and women ages ≥ 18 years old
Documented or suspected infection
Severe sepsis or septic shock for at least 24 hours
Sepsis-induced immunosuppression
In Intensive Care Unit (ICU) with no plans to discharge in next 24 hours
You may not be if
Previous episode of severe sepsis or septic shock with ICU admission during the current hospitalization
Autoimmune disease
Organ or bone marrow transplant
Cancer treatment in the past 6 weeks
Human immunodeficiency virus (HIV) infection and not on therapy prior to this episode of sepsis; hepatitis C virus(HCV) infection and still has virus (not cured); Chronic hepatitis B virus (HBV) infection and not on treatment
Clareo Health | A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock.
